Galeon's MEXC Listing Aligns Incentives to Catalyze Health Outcomes

Galeon, a decentralized science (DeSci) and healthcare AI platform, has listed its native token $GALEON on MEXC, marking a pivotal expansion of its Web3-enabled healthcare ecosystem. The move, announced on October 14, 2025, positions the project to leverage MEXC's global user base to amplify participation in its research and governance frameworks. With its electronic health record (EHR) system already operational in 18 European hospitals, Galeon aims to align blockchain-driven liquidity with real-world medical infrastructure, a Coin Edition report.

The listing follows Galeon's high-profile collaboration with Samsung, which integrates AI-powered ultrasound devices with Galeon's EHR platform. This partnership, active in France's Rouen and Caen University Hospitals, enables real-time data analysis while maintaining strict patient privacy. By anonymizing data before processing and retaining institutional control, the system allows hospitals to collaboratively train AI models without centralizing sensitive information, according to CoinCentral. Dr. Loïc Brotons, Galeon's CEO, emphasized that the MEXC listing "aligns incentives between caregivers, patients, and innovators," transforming liquidity into a "catalyst for health outcomes," Coin Edition reported.

Central to Galeon's approach is its Blockchain Swarm Learning (BSL) framework, which decentralizes AI training across anonymized datasets. This technology not only adheres to stringent privacy regulations but also accelerates diagnostic accuracy and reduces administrative burdens for healthcare providers. The EHR system, used by over 10,000 caregivers monthly, generates structured records that refine AI models while cutting clerical workloads, Coin Edition reported. Outside hospitals, the Atlantis platform and $GALEON token engage a community of 100,000+ participants in funding and governing medical research, democratizing innovation priorities.

The MEXC listing underscores Galeon's broader ambitions to extend its footprint beyond women's health into diagnostics and global research. By uniting investors, hospitals, and developers, the project seeks to redefine decentralized healthcare. Analysts note that Samsung's hardware expertise combined with Galeon's blockchain traceability could drive adoption in AI-driven diagnostics, potentially boosting both the DeSci sector and related token valuations.